This is the authors' abstract. We don't add key points for this paper.
The COVID-19 Pandemic upended the lives of nearly everyone worldwide, and recent studies have reported higher rates of anxiety, depression, and other mental health problems. Using a repeated crosssectional design, the current study compares anxiety levels from a representative sample of college students prior-to and during the COVID-19 Pandemic. Additionally, differences in anxiety prior to and following U.S. approval for use of the Pfizer-BioNTtech COVID-19 vaccine were also compared. Findings indicate that state-anxiety levels did not differ significantly prior to and during the Pandemic as well as before the vaccine and during and after the vaccine ( M = 43.01, 44.10, 44.77, respectively). Surprisingly, trait anxiety levels were significantly higher during the Pandemic than before ( p = .003), and anxiety levels trend down after the approval of the vaccine, but not significantly ( M = 45.10, 48.85, 47.58, respectively). Future research should continue to investigate and compare anxiety levels during the COVID-19 Pandemic.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Voss et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: